Editorial Team
🇪🇺 EMANamed contributors covering Europe & United Kingdom pharmaceutical intelligence — 2 editors with published articles.
Quick answer
NovaPharmaNews Europe & United Kingdom edition lists 2 named editorial contributors with 517 published articles — EMA drug approvals, clinical trials, manufacturing, and market intelligence attributed to accountable experts.
Contributors
-
James Park Regulatory Affairs Editor 263 articles Writes on FDA, EMA, and global regulatory pathways, translating submissions, approvals, and guidance into actionable intelligence. -
Robert Kim Senior Science Editor 254 articles Science editor covering oncology, immunotherapy, and mechanism-of-action explainers for a professional pharma audience.
Frequently asked questions
Who are the NovaPharmaNews editorial contributors?
This directory lists regional editors and analysts with published intelligence on NovaPharmaNews. Each profile shows credentials, coverage focus, and a full article archive for transparency and E-E-A-T.
How is regional coverage organised?
Authors are grouped by regional edition — Americas (FDA), Europe (EMA), or Asia-Pacific (PMDA/NMPA). Open a profile to see that contributor’s published news and analysis.
Where can I read the editorial standards?
See our Editorial Policy and Methodology pages for sourcing rules, correction process, and how human experts validate AI-assisted analysis.